GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (NAS:DXCM) » Definitions » Cyclically Adjusted PB Ratio

DexCom (DexCom) Cyclically Adjusted PB Ratio : 40.77 (As of Apr. 28, 2024)


View and export this data going back to 2005. Start your Free Trial

What is DexCom Cyclically Adjusted PB Ratio?

As of today (2024-04-28), DexCom's current share price is $124.34. DexCom's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.05. DexCom's Cyclically Adjusted PB Ratio for today is 40.77.

The historical rank and industry rank for DexCom's Cyclically Adjusted PB Ratio or its related term are showing as below:

DXCM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 27.11   Med: 58.51   Max: 124.32
Current: 40.78

During the past years, DexCom's highest Cyclically Adjusted PB Ratio was 124.32. The lowest was 27.11. And the median was 58.51.

DXCM's Cyclically Adjusted PB Ratio is ranked worse than
99.12% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs DXCM: 40.78

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

DexCom's adjusted book value per share data for the three months ended in Mar. 2024 was $5.392. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.05 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


DexCom Cyclically Adjusted PB Ratio Historical Data

The historical data trend for DexCom's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Cyclically Adjusted PB Ratio Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.20 81.33 78.75 48.86 42.44

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.61 48.54 33.22 42.44 45.49

Competitive Comparison of DexCom's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, DexCom's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where DexCom's Cyclically Adjusted PB Ratio falls into.



DexCom Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

DexCom's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=124.34/3.05
=40.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, DexCom's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.392/129.4194*129.4194
=5.392

Current CPI (Mar. 2024) = 129.4194.

DexCom Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.330 100.560 0.425
201409 0.376 100.428 0.485
201412 0.453 99.070 0.592
201503 0.469 99.621 0.609
201506 0.533 100.684 0.685
201509 0.594 100.392 0.766
201512 0.677 99.792 0.878
201603 0.693 100.470 0.893
201606 0.735 101.688 0.935
201609 0.775 101.861 0.985
201612 0.839 101.863 1.066
201703 0.805 102.862 1.013
201706 1.022 103.349 1.280
201709 1.105 104.136 1.373
201712 1.205 104.011 1.499
201803 1.197 105.290 1.471
201806 1.363 106.317 1.659
201809 1.583 106.507 1.924
201812 1.843 105.998 2.250
201903 1.837 107.251 2.217
201906 1.887 108.070 2.260
201909 2.088 108.329 2.495
201912 2.409 108.420 2.876
202003 2.531 108.902 3.008
202006 3.548 108.767 4.222
202009 3.904 109.815 4.601
202012 4.752 109.897 5.596
202103 4.920 111.754 5.698
202106 5.164 114.631 5.830
202109 5.511 115.734 6.163
202112 5.263 117.630 5.791
202203 5.579 121.301 5.952
202206 5.746 125.017 5.948
202209 4.724 125.227 4.882
202212 5.519 125.222 5.704
202303 5.761 127.348 5.855
202306 5.440 128.729 5.469
202309 5.869 129.860 5.849
202312 5.367 129.419 5.367
202403 5.392 129.419 5.392

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


DexCom  (NAS:DXCM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


DexCom Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of DexCom's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom (DexCom) Business Description

Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Executives
Sadie Stern officer: Chief Human Resources Officer 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Steven R Altman director
Kevin R Sayer director
Jereme M Sylvain officer: SVP, Finance & CAO 6340 SEQUENCE DRIVE, SAN DIEGO X1 92121
Jacob Steven Leach officer: SVP, Research & Development 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Nicholas Augustinos director 754 GRAND VIEW AVENUE, SAN FRANCISCO CA 94114
Micheal Jon Brown officer: EVP, Chief Legal Officer 6340 SEQUENCE DR, SAN DIEGO CA 92121
Steven Robert Pacelli officer: Vice President Legal Affairs 5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Girish Naganathan officer: EVP Chief Technology Officer C/O DEXCOM, INC., 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Barry J. Regan officer: EVP Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Bridgette P Heller director TECH DATA CORPORATION, 5350 TECH DATA DRIVE, CLEARWATER FL 33760
Matthew Vincent Dolan officer: * 6340 SEQUENCE DR, SAN DIEGO CA 92121
Rimma Driscoll director C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
Shelly Ramasamy Selvaraj officer: SVP Information Technology 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121
Paul R Flynn officer: EVP, Global Revenue 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121

DexCom (DexCom) Headlines

From GuruFocus

Q1 2022 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2022 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Dexcom Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Dexcom Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024